glp-1 effect on cholesterol Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 Genetics: How Genes Affect
Description
Additional research is required to ascertain the variability in the risk of biliary diseases associated with GLP-1 RAs

Notably, GLP-1(936) had no glucagonostatic effect in the presence of REMD2.59

Glucagon Receptor Agonist Glucagon receptor has been localized to the brain and pancreas, as well as the heart, kidney, liver, and adipose tissue, suggesting pleiotropic effects in the body [41]

[3] Klein S, et al

57 UPR is mainly involved in the activation of three transmembrane proteins, inositol-requiring enzyme 1 (IRE-1), activating transcription factor 6 (ATF6), and protein kinase R (PKR)-like ER kinase (PERK)

Ozempic and Rybelsus are both semaglutide one a weekly injection, the other a daily tablet
